Higher Adherence to the Mediterranean Dietary Pattern Is Inversely Associated With Severity of COVID-19 and Related Symptoms: A Cross-Sectional Study

Background and AimsAdherence to the Mediterranean diet (MD) has been associated with a decreased risk of developing a variety of chronic diseases that are comorbidities in COVID-19 patients. However, its association to the severity and symptoms of COVID-19 are still unknown. This study aimed to examine the association between adherence to the MD pattern and COVID-19 severity and symptoms in Iranian hospitalized patients.MethodsIn this cross-sectional study, 250 COVID-19 patients aged 18 to 65 were examined. We employed a food frequency questionnaire (FFQ) to obtain data on dietary intake of participants in the year prior to their COVID-19 diagnosis. COVID-19 severity was determined using the National Institutes of Health's Coronavirus Disease 2019 report. Additionally, symptoms associated with COVID-19, inflammatory markers, and other variables were evaluated. The scoring method proposed by Trichopoulou et al. was used to assess adherence to the MD.ResultsThe participants' mean age was 44.1 ± 12.1 years, and 46% of them had severe COVID-19. Patients who adhered more closely to the MD had lower serum C-reactive protein levels (7.80 vs. 37.36 mg/l) and erythrocyte sedimentation rate (14.08 vs. 42.65 mm/h). Those with the highest MD score were 77% less likely to have severe COVID-19 after controlling for confounding variables. The MD score was also found to be inversely associated with COVID-19 symptoms, including dyspnea, cough, fever, chills, weakness, myalgia, nausea and vomiting, and sore throat.ConclusionHigher adherence to the MD was associated with a decreased likelihood of COVID-19 severity and symptoms, as well as a shorter duration of hospitalization and convalescence, and inflammatory biomarkers

Small-molecule-induced DNA damage identifies alternative DNA structures in human genes.

Guanine-rich DNA sequences that can adopt non-Watson-Crick structures in vitro are prevalent in the human genome. Whether such structures normally exist in mammalian cells has, however, been the subject of active research for decades. Here we show that the G-quadruplex-interacting drug pyridostatin promotes growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage. A chromatin immunoprecipitation sequencing analysis of the DNA damage marker γH2AX provided the genome-wide distribution of pyridostatin-induced sites of damage and revealed that pyridostatin targets gene bodies containing clusters of sequences with a propensity for G-quadruplex formation. As a result, pyridostatin modulated the expression of these genes, including the proto-oncogene SRC. We observed that pyridostatin reduced SRC protein abundance and SRC-dependent cellular motility in human breast cancer cells, validating SRC as a target of this drug. Our unbiased approach to define genomic sites of action for a drug establishes a framework for discovering functional DNA-drug interactions

Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo

Abstract Small interfering RNA (siRNA)-based drugs require chemical modifications or formulation to promote stability, minimize innate immunity, and enable delivery to target tissues. Partially modified siRNAs (up to 70% of the nucleotides) provide significant stabilization in vitro and are commercially available; thus are commonly used to evaluate efficacy of bio-conjugates for in vivo delivery. In contrast, most clinically-advanced non-formulated compounds, using conjugation as a delivery strategy, are fully chemically modified (100% of nucleotides). Here, we compare partially and fully chemically modified siRNAs in conjugate mediated delivery. We show that fully modified siRNAs are retained at 100x greater levels in various tissues, independently of the nature of the conjugate or siRNA sequence, and support productive mRNA silencing. Thus, fully chemically stabilized siRNAs may provide a better platform to identify novel moieties (peptides, aptamers, small molecules) for targeted RNAi delivery

Biological control of garlic (Allium) white rot disease using antagonistic fungi-based bioformulations

White rot disease caused by Sclerotium cepivorum is a major yield reducing fungal disease of garlic found throughout the world, including Iran. The use of chemical fungicides is the most common control method for the disease at the present time. This control measure is costly, contaminates the environment, and harms non-target organisms. Moreover, since the pathogen is soil-borne, chemical control strategy is not quite effective against the disease. In this study, we tried to develop and prepare some new bioformulations based on three antagonistic fungal species: Trichoderma harzianum, T. asperellum, and Talaromyces flavus. Six isolates of the abovementioned fungi were used along with the organic and inorganic carriers, rice bran and talc, to develop twelve new bioformulations. The effectiveness of the bioformulations were then evaluated in the control of garlic white rot disease in the greenhouse conditions in comparison with the healthy control, infected control, and the commonly used fungicide Carbendazim. The design of the experiment was completely randomised. There were 15 treatments each, with four replicates. The results of the greenhouse experiments indicated that almost all the developed bioformulations resulted in significant reductions (34.50 to 64.50%) in the incidence of white rot disease. In general, bioformulations which contained the organic carrier (rice bran) performed more effectively than those that contained the inorganic carrier (talc). Bioformulations which contained an organic carrier (rice bran) were as effective as the fungicide Carbendazim

Resource utilization and costs of managing patients with advanced melanoma: A canadian population-based study

© 2017 Multimed Inc. Background The use and detailed costs of services provided for people with advanced melanoma (amel) are not well known. We conducted an analysis to determine the use of health care services and the associated costs delineated by relevant attributable costs, which we defined for subjects in the province of Ontario. Methods Through the Ontario Cancer Data Linkage Project, a cohort of amel patients with diagnoses between 31 August 2005 and 2012 (follow-up to 2013) and with valid International Classification of Diseases (9th revision, Clinical Modification) 172 codes and histology codes was identified. A cohort of individuals with amel having a combination of at least 1 palliative, 1 medical oncology, and 1 hospitalization code was generated. The health system services used by this population were clustered into hospitalization, palliation, physician medical visits, medication, homecare, laboratory, diagnostics, and other resources. Overall rates of use and disaggregated costs were determined by phase of care for the entire cohort. Results The mean age for the 2748 individuals in the cohort was 67 years. The greater proportion of the patients were men (65.6%) and were more than 65 years of age (>50%). In this advanced cohort, fewer than 45% of patients were alive 3 years after the malignant melanoma diagnosis. The average annual cost per patient over the time horizon was $6,551. At$15,830, year 1 after diagnosis was the most expensive, followed by year 2, at $8,166. Conclusions Our data provide a baseline for the costs associated with amel treatment. Future studies will include newer agents and comparative effectiveness research for personalized therapies

Hybridization of Block-Pulse and Taylor Polynomials for Approximating 2D Fractional Volterra Integral Equations

This paper proposes an accurate numerical approach for computing the solution of two-dimensional fractional Volterra integral equations. The operational matrices of fractional integration based on the Hybridization of block-pulse and Taylor polynomials are implemented to transform these equations into a system of linear algebraic equations. The error analysis of the proposed method is examined in detail. Numerical results highlight the robustness and accuracy of the proposed strategy

A quadrafunctional electrocatalyst of nickel/nickel oxide embedded N-graphene for oxygen reduction, oxygen evolution, hydrogen evolution and hydrogen peroxide oxidation reactions

A multifunctional nano-heterostructured electrocatalyst of transition metal/metal oxide (nickel/nickel oxide) embedded on nitrogen-doped graphene is reported. The hybrid composite of N-doped graphene nanosheets with a high atomic percentage of nitrogen (8.2 at%) and embedded with highly distributed nickel/nickel oxide nanoparticles inside the graphene layers is synthesized by a one pot thermal annealing process. The resultant composite demonstrates excellent electrocatalytic activity utilizing the superior electrocatalytic properties of nickel/nickel oxide nanoparticles supported on nitrogen-doped graphene. The hybrid exhibits efficient oxygen reduction reaction (ORR) properties comparable with state-of-the-art electrode Pt/C with a four-electron transfer pathway and superior oxygen evolution reaction (OER) compared to the state-of-the-art electrode for the OER, Ru/C. Alternatively, this composite acts as an excellent electrode material for the hydrogen evolution reaction (HER) both in acidic and alkaline media. Nevertheless, this composite facilitates the hydrogen peroxide oxidation reaction (HPOR) in the presence of hydrogen peroxide, which is crucial for developing reversible fuel cells and fuel cells with liquid oxidant